No abstract available
MeSH terms
-
Fluorobenzenes / therapeutic use*
-
Follow-Up Studies
-
Heart Failure / blood
-
Heart Failure / drug therapy*
-
Heart Failure / epidemiology
-
Humans
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
-
Morbidity / trends
-
Multicenter Studies as Topic
-
Natriuretic Peptide, Brain / blood
-
Peptide Fragments / blood
-
Prognosis
-
Protein Precursors
-
Pyrimidines / therapeutic use*
-
Randomized Controlled Trials as Topic
-
Risk Factors
-
Rosuvastatin Calcium
-
Sulfonamides / therapeutic use*
-
Survival Rate / trends
-
Time Factors
-
United States / epidemiology
Substances
-
Fluorobenzenes
-
Hydroxymethylglutaryl-CoA Reductase Inhibitors
-
Peptide Fragments
-
Protein Precursors
-
Pyrimidines
-
Sulfonamides
-
pro-brain natriuretic peptide (1-76)
-
Natriuretic Peptide, Brain
-
Rosuvastatin Calcium